Research Catalog

Examining oversight reports on the 340B Drug Pricing Program : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, second session, on examining oversight reports on the 340B Drug Pricing Program, May 15, 2018.

Title
Examining oversight reports on the 340B Drug Pricing Program : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, second session, on examining oversight reports on the 340B Drug Pricing Program, May 15, 2018.
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions, author.
Publication
Washington : U.S. Government Publishing Office, 2020.

Details

Description
iii, 46 pages; 24 cm.
Series Statement
  • S. hrg. ; 115-240
  • United States. Congress. Senate. S. hrg. ; 115-240.
Subject
  • 340B Drug Pricing Program (U.S.) > Auditing
  • United States. Health Resources and Services Administration > Rules and practice
  • United States. Health Resources and Services Administration
  • Drug accessibility > Government policy > United States
  • Drugs > Prices > Government policy > United States
  • Prescription pricing > Government policy > United States
  • Auditing
  • Drugs > Prices > Government policy
  • Prescription pricing > Government policy
  • United States
Genre/Form
  • Legislative hearings.
  • Rules.
Note
  • Shipping list no.: 2021-0014-M.
Bibliography (note)
  • Includes bibliographical references.
Event (note)
  • Date of hearing: 2018-05-15.
Reproduction (note)
  • Microfiche.
Call Number
GPO Microfiche Y 4.L 11/4:S.HRG.115-240
LCCN
30-195
OCLC
marcive1280061505
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions, author.
Title
Examining oversight reports on the 340B Drug Pricing Program : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, second session, on examining oversight reports on the 340B Drug Pricing Program, May 15, 2018.
Publisher
Washington : U.S. Government Publishing Office, 2020.
Type of Content
text
Type of Medium
microform
Type of Carrier
microfiche
Series
S. hrg. ; 115-240
United States. Congress. Senate. S. hrg. ; 115-240.
Bibliography
Includes bibliographical references.
Performer
Hearing witnesses: Maxwell, Ann, Assistant Inspector General for Evaluation and Inspections, Office of the Inspector General, U.S. Department of Health and Human Services, Washington, DC; Draper, Debra A., Ph.D., Director, Health Care Team, U.S. Government Accountability Office, Washington, DC.
Event
Date of hearing: 2018-05-15.
Reproduction
Microfiche. [Washington, D.C.] : U.S. Government Publishing Office, [2020?] 1 microfiche : negative.
Other Form:
Print version: United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Examining oversight reports on the 340B Drug Pricing Program (OCoLC)1158019485
Online version: United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Examining oversight reports on the 340B Drug Pricing Program (OCoLC)1156626520
Other Standard Identifier
30-195 (GPO jacket number)
Gpo Item No.
1043-B (MF)
Sudoc No.
Y 4.L 11/4:S.HRG.115-240
View in Legacy Catalog